| 產(chǎn)品名稱 | BMS 204352, (±)- |
| 產(chǎn)品貨號(hào) | Axon 1308 CAS [183720-28-7] MF C16H10ClF4NO2MW 359.70 Purity: 98% Soluble in DMSO Description Potassium channel opener; racemate of more active S-(+)-enantiomer, BMS-204352 (Flindokalner, Axon 1112), and less active R-(-)-enantiomer (Axon 1309) References Certificates Categories Extra info Krishna R et al. Pharmacokinetics and dose proportionality of BMS-204352 after intraarterial administration to rats. Biopharm Drug Dispos. 2002, 23(6), 233-7. ? M. P. G. Korsgaard et al. Anxiolytic Effects of Maxipost (BMS-204352) and Retigabine via Activation of Neuronal Kv7 Channels. J. Pharmacol. Exp. Ther. 2005, 314, 282-292. Certificate of Analysis Material Safety Data Sheet Cardiovascular CNS KCa1.1 KCNMA1 Potassium channel opener; racemate of Axon 1112 Chemical name 3-(5-Chloro-2-methoxy-phenyl)-3-fluoro-6-trifluoromethyl-1,3-dihydro-indol-2-one Parent CAS No. [183720-28-7] Inquire |
| 產(chǎn)品價(jià)格 | 現(xiàn)貨詢價(jià)，電話：010-67529703 |
| 產(chǎn)品規(guī)格 | |
| 產(chǎn)品品牌 | axonmedchem |
| 產(chǎn)品概述 | |
| 產(chǎn)品詳情 |
BMS 204352, (±)-Axon 1308 CAS [183720-28-7] MF C16H10ClF4NO2
Description
Potassium channel opener; racemate of Axon 1112
Chemical name3-(5-Chloro-2-methoxy-phenyl)-3-fluoro-6-trifluoromethyl-1,3-dihydro-indol-2-one Parent CAS No.[183720-28-7] |
| 產(chǎn)品資料 |
